cm 0525 medium (Procell Inc)
Structured Review
Cm 0525 Medium, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cm+0525+medium/0525+cm+medium/pm41605797-70-6-8
Average 86 stars, based on 1 article reviews
Images
Related Articles
Cell Culture:Article Title: Astragalus Polysaccharide Attenuates Breast Cancer Progression by Regulating METTL3-Mediated MAL2 m 6 A Modification Article Snippet: Human normal breast epithelial cell line MCF-10A (cat. no. CL-0525), and two BC cell lines including MCF-7 (cat. no. CL-0149) and MDA-MB-231 (cat. no. CL-0150) were purchased from Procell, China. .. The MCF-10A cells were cultured in Article Title: Astragalus Polysaccharide Attenuates Breast Cancer Progression by Regulating METTL3-Mediated MAL2 m 6 A Modification. Article Snippet: Introduction Breast cancer (BC) is the most widespread malignancy that affects females globally, with more than 2.3 million cases and nearly 665,000 deaths reported alone in the year 2022 [1].. BC is a complex disease driven by both genetic and environmental factors, with current treatment options including surgery, chemoradiotherapy, endocrine therapy, and targeted therapy widely used in clinical practice [2].. Nonetheless, while various chemo preventive drugs are effectively used to treat BC, challenges such as chemoresistance and metastasis persist in certain patients, particularly in triple-negative BC, often resulting in a poor prognosis [3]. Incubation:Article Title: Astragalus Polysaccharide Attenuates Breast Cancer Progression by Regulating METTL3-Mediated MAL2 m 6 A Modification Article Snippet: Human normal breast epithelial cell line MCF-10A (cat. no. CL-0525), and two BC cell lines including MCF-7 (cat. no. CL-0149) and MDA-MB-231 (cat. no. CL-0150) were purchased from Procell, China. .. The MCF-10A cells were cultured in Article Title: Astragalus Polysaccharide Attenuates Breast Cancer Progression by Regulating METTL3-Mediated MAL2 m 6 A Modification. Article Snippet: Introduction Breast cancer (BC) is the most widespread malignancy that affects females globally, with more than 2.3 million cases and nearly 665,000 deaths reported alone in the year 2022 [1].. BC is a complex disease driven by both genetic and environmental factors, with current treatment options including surgery, chemoradiotherapy, endocrine therapy, and targeted therapy widely used in clinical practice [2].. Nonetheless, while various chemo preventive drugs are effectively used to treat BC, challenges such as chemoresistance and metastasis persist in certain patients, particularly in triple-negative BC, often resulting in a poor prognosis [3]. |
